Delphine Rea

Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate

J. Cayuela, H. Dombret, A. Toubert, 2004, Leukemia.

Usefulness of the 2012 European CVD risk assessment model to identify patients at high risk of cardiovascular events during nilotinib therapy in chronic myeloid leukemia

H. Dombret, E. Messas, P. Rousselot, 2014, Leukemia.